The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Validation of the JCOG prognostic index in advanced gastric cancer of the SPIRITS and G-SOX trials, using individual patient data.
 
Daisuke Takahari
Honoraria - Chugai Pharma; Lilly Japan; Taiho Pharmaceutical; Yakult Pharmaceutical
Consulting or Advisory Role - Lilly Japan
 
Junki Mizusawa
Speakers' Bureau - Chugai Pharma
 
Wasaburo Koizumi
No Relationships to Disclose
 
Ichinosuke Hyodo
Honoraria - Chugai Pharma; Daiichi Sankyo; Taiho Pharmaceutical; Yakult Pharmaceutical
Consulting or Advisory Role - Daiichi Sankyo; Sanofi; Taiho Pharmaceutical; Yakult Pharmaceutical
Research Funding - Chugai Pharma (Inst); Daiichi Sankyo (Inst); Yakult Pharmaceutical (Inst)
 
Narikazu Boku
Honoraria - Chugai Pharma; Daiichi Sankyo; Lilly Japan; Merck Serono; Ono Pharmaceutical; Shionogi; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst)